PRECISIONBIOLOGICS
Menu
↗
Regulatory

Google Ads policies notes for regenerative clinics

High-level notes on how regenerative clinics should approach paid search without restricted medical claims.

Reviewed 2026-10-27

Expect restrictions

Paid platforms often limit healthcare and stem-cell related claims. Build pages that emphasize documentation and account access rather than disease outcomes.

Have counsel and your media buyer review before launch.

Landing page alignment

Ads and landing pages must match. Mismatched medical claims are a common disapproval reason.

Track account applications and qualified clinic leads, not promised patient outcomes.

Measure clinic leads, not outcomes

Measure success as verified clinic leads and completed documentation packs.

Do not use paid search metrics as evidence of clinical performance.

Operational checklist for Google Ads regenerative medicine clinics

Before ordering under the topic Google Ads regenerative medicine clinics, confirm storage class, receiving owner, and which documents will be required at release.

Close open items in writing. Do not infer missing COA fields from a different lot or SKU.

FAQ

Frequently asked questions

Does Precision Biologics certify regulatory status for our use?+

No. Classification and intended-use determinations belong to the ordering physician and clinic counsel.

Is this legal advice?+

No. This is general information for licensed healthcare professionals.

Can account approval replace counsel review?+

No. Account verification is administrative only.

Does this page determine how we may use products discussed under Google Ads regenerative medicine clinics?+

No. Intended use remains with the ordering physician and clinic counsel.

Sources

  1. FDA: Minimal Manipulation and Homologous Use guidance ↗FDA
  2. 21 CFR Part 1271 ↗eCFR